#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3880148	B	Inhibition of A-Raf (unknown origin) assessed as decrease in biotin-tagged MEK1 phosphorylation after 45 mins	Homo sapiens	34		single protein format	Patent Bioactivity Data
2.	ALA3880149	B	Inhibition of B-Raf (unknown origin) assessed as decrease in biotin-tagged MEK1 phosphorylation after 45 mins	Homo sapiens	90		single protein format	Patent Bioactivity Data
3.	ALA3880150	B	Inhibition of B-Raf V600E mutant (unknown origin) assessed as decrease in biotin-tagged MEK1 phosphorylation after 45 mins	Homo sapiens	91		single protein format	Patent Bioactivity Data
4.	ALA3880153	F	Cytotoxicity against human A375 cells expressing B-RAF V600E mutant assessed as growth inhibition after 3 days by ATPlite 1 step luminescence assay	Homo sapiens	90		cell-based format	Patent Bioactivity Data
5.	ALA3880154	F	Cytotoxicity against human COLO205 cells expressing B-RAF V600E mutant assessed as growth inhibition after 3 days by ATPlite 1 step luminescence assay	Homo sapiens	74		cell-based format	Patent Bioactivity Data
6.	ALA3880158	F	Cytotoxicity against human SK-MEL-2 cells expressing Ras mutant assessed as growth inhibition at 10 uM after 3 days by ATPlite 1 step luminescence assay	Homo sapiens	41		cell-based format	Patent Bioactivity Data
7.	ALA3880159	F	Cytotoxicity against human SW620 cells expressing Ras mutant assessed as growth inhibition at 10 uM after 3 days by ATPlite 1 step luminescence assay	Homo sapiens	62		cell-based format	Patent Bioactivity Data
8.	ALA3880160	F	Antitumor activity against human COLO205 cells xenografted in nu/nu mouse assessed as tumor growth inhibition at 10 mg/kg administered for 14 days measured twice a week during compound dosing relative to control	Homo sapiens	15		organism-based format	Patent Bioactivity Data
9.	ALA3880161	A	Aqueous solubility of the compound in simulated gastric fluid at pH 1.5		65		tissue-based format	Patent Bioactivity Data
10.	ALA3880162	A	Aqueous solubility of the compound in simulated intestinal fluid at pH 4.5		65		assay format	Patent Bioactivity Data
11.	ALA3880163	A	Aqueous solubility of the compound in simulated intestinal fluid at pH 6.8		65		assay format	Patent Bioactivity Data
12.	ALA3880164	P	Aqueous solubility of the compound in hepes buffer at pH 7.4		65		small-molecule physicochemical format	Patent Bioactivity Data
13.	ALA3880165	A	Inhibition of CYP1A2 (unknown origin) using CEC as substrate after 15 mins	Homo sapiens	85		single protein format	Patent Bioactivity Data
14.	ALA3880166	A	Inhibition of CYP2C19 (unknown origin) using CEC as substrate after 30 mins	Homo sapiens	84		single protein format	Patent Bioactivity Data
15.	ALA3880167	A	Inhibition of CYP2C9 (unknown origin) using MFC as substrate after 45 mins	Homo sapiens	85		single protein format	Patent Bioactivity Data
16.	ALA3880168	A	Inhibition of CYP2D6 (unknown origin) using AMMC as substrate after 30 mins	Homo sapiens	85		single protein format	Patent Bioactivity Data
17.	ALA3880169	A	Inhibition of CYP3A4 (unknown origin) using BFC as substrate after 30 mins	Homo sapiens	85		single protein format	Patent Bioactivity Data
18.	ALA3880170	A	Inhibition of CYP3A4 (unknown origin) using BQ as substrate after 30 mins	Homo sapiens	85		single protein format	Patent Bioactivity Data